Physician profile
Daniel Lee
NPI 1871818880
$10,761.83
in general payments reported to CMS, 2019-2025
12 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,238 · 2020: $3,012 · 2021: $189 · 2022: $252 · 2023: $5,408 · 2024: $281 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,439 · Travel and Lodging: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,439.14 |
| Travel and Lodging | $630.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,942.37 | 2020-2023 | Da Vinci Surgical System |
| Allergan, INC. | $1,105.61 | 2019 | |
| Photocure INC | $408.20 | 2021-2023 | Cysview |
| Janssen Biotech, INC. | $404.87 | 2024-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $307.25 | 2022-2025 | |
| Acclarent, INC | $247.29 | 2023 | Trudi Nav Cable |
| Karl Storz Endoscopy-America | $132.66 | 2019 | |
| Baxter Healthcare | $59.35 | 2023-2024 | Perclot |
| Ferring Pharmaceuticals INC. | $48.87 | 2025 | Adstiladrin |
| Boston Scientific Corporation | $46.55 | 2023 | Ams 700 |
| Janssen Scientific Affairs, LLC | $33.73 | 2025 | |
| Coloplast Corp | $25.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.